alexa Pharmacokinetics of aminoglycosides in patients with chronic spinal cord injury.
Toxicology

Toxicology

Journal of Drug Metabolism & Toxicology

Author(s): Young F, Ensom MH

Abstract Share this page

Abstract PURPOSE: The pharmacokinetics of amino-glycosides in patients with chronic spinal cord injury (SCI) is reviewed. SUMMARY: SCI is associated with many physiological changes that can affect disposition of drugs such as aminoglycosides; therefore, dosing of aminoglycosides in this population can be challenging. In general, volume of distribution is significantly higher in the SCI population compared with the non-SCI population; however, clearance and half-life may be larger or no different. When gentamicin is administered intramuscularly, there is no difference in bioavailability when the dose is administered below the level of the injury but absorption appears to be slower in patients with SCI compared with the non-SCI population. Several methods of laboratory assessment of renal function, such as serum creatinine (SCr), 24-hour urine creatinine clearance (CL(cr)), and cystatin C, have advantages and limitations associated with their use in the SCI population. The majority of evidence suggests that SCr and various estimation equations are not accurate methods for assessing renal function in this population. Although measured CL(cr) by 24-hour urine collection is not dependent on muscle mass, wide intrapatient variability in CL(cr) results is still observed. Cystatin C may be a good option in this population; however, its use is limited by its availability. CONCLUSION: Determining appropriate aminoglycoside dosage in patients with SCI is challenging because such patients exhibit physiological changes that lead to their having different aminoglycoside pharmacokinetic values than the general population. Monitoring of aminoglycoside concentrations and calculation of patient-specific pharmacokinetic values can help guide dosage in this patient population. This article was published in Am J Health Syst Pharm and referenced in Journal of Drug Metabolism & Toxicology

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materials[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords